20 LATEST RESOURCES (433 INDEXED)
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder · December 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study · November 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study · August 2023
Articles
Journal of Child and Adolescent Psychopharmacology
D-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial · June 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate · May 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study · March 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day · February 2023
Articles
Journal of Child and Adolescent Psychopharmacology
Preliminary Observations of Resting-State Magnetoencephalography in Nonmedicated Children with Obsessive-Compulsive Disorder · December 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder · November 2022
Articles
Journal of Child and Adolescent Psychopharmacology
Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder · June 2022
Articles
Journal of Child and Adolescent Psychopharmacology
A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales · June 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders · May 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial · May 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder · May 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
A Preclinical Study of Standard versus Accelerated Transcranial Magnetic Stimulation for Depression in Adolescents · April 2022
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder · March 2022
Articles
Journal of Child and Adolescent Psychopharmacology
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study · March 2022
Articles
Journal of Child and Adolescent Psychopharmacology
Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder · February 2022
Articles
Journal of Child and Adolescent Psychopharmacology
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study · February 2022
Articles
Journal of Child and Adolescent Psychopharmacology
Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners · February 2022
Articles
Journal of Child and Adolescent Psychopharmacology